banner
Ovarian cancer-targeted nanolipid microbubble contrast agents
Inquiry

Cat. No.: X26-05-ZQ2390

Ovarian cancer-targeted nanolipid microbubble contrast agents

Synonym: Ovarian cancer-targeted nanolipid MB contrast agents; Ovarian cancer-targeted nanolipid microbubbles; Ovarian cancer-targeted lipid MB contrast agents

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This advanced engineered multi-phase formulation features ovarian cancer targeted lipid-stabilized sub-micron microbubbles. The sub-micron architecture consists of a gaseous core (composed of high-molecular-weight perfluorocarbon gases) encapsulated within a monolayer shell of phospholipids and pegylated lipids whose outer surface is functionalized with specific ovarian cancer target-mimetic antibodies or peptide links. This complex layout balances a dense target-mimetic macromolecular array with the acoustic resonance and echogenic parameters of a compressed gas core, completely preventing gas dissolution and physical bubble aggregation under ambient laboratory testing conditions.
Source
Custom synthesis
Functional Group
Ovarian cancer Lipid microbubble
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.